| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2014 | US20140107193 Nutritional composition containing a neurologic component of kaempferol and/or fisetin and uses thereof |
| 04/17/2014 | US20140107192 Cannabinoids for use in the treatment of neuropathic pain |
| 04/17/2014 | US20140107191 Method for enhanced uptake of viral vectors in the myocardium |
| 04/17/2014 | US20140107188 Use of hgma-targeted phosphorothioate dna aptamers to suppress carcinogenic activity and increase sensitivity to chemotherapy agents in human cancer cells |
| 04/17/2014 | US20140107180 Modulation of androgen receptor expression |
| 04/17/2014 | US20140107179 ORGANIC COMPOSITIONS TO TREAT Beta-ENaC-RELATED DISEASES |
| 04/17/2014 | US20140107177 Methods and Compositions for Transdermal Delivery of Nucleotides |
| 04/17/2014 | US20140107173 Compositions and Methods for Treatment of Glaucoma |
| 04/17/2014 | US20140107172 Benzimidazole-imidazole derivatives |
| 04/17/2014 | US20140107171 Methods of Treating an Overweight or Obese Subject |
| 04/17/2014 | US20140107170 Composition comprising angiotensin ii receptor antagonist and antioxidant for maintaining and/or improving skin properties |
| 04/17/2014 | US20140107169 Parenteral formulation for epothilone analogs |
| 04/17/2014 | US20140107167 Pharmaceutical composition and a process thereof |
| 04/17/2014 | US20140107166 Histone deacetylase inhibitors and methods of use thereof |
| 04/17/2014 | US20140107163 Synthesis and novel salt forms of (r)-3-((e)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine |
| 04/17/2014 | US20140107160 Ccr9 inhibitors and methods of use thereof |
| 04/17/2014 | US20140107156 Novel Amino Azaheterocyclic Carboxamides |
| 04/17/2014 | US20140107154 Laquinimod for reducing thalamic damage in multiple sclerosis |
| 04/17/2014 | US20140107152 Sensory receptors for chronic fatigue and pain and uses |
| 04/17/2014 | US20140107151 Tyrosine kinase inhibitors |
| 04/17/2014 | US20140107149 Parasiticidal dihydroisoxazole compounds |
| 04/17/2014 | US20140107147 Antineoplastic Combinations Containing HKI-272 and Vinorelbine |
| 04/17/2014 | US20140107146 Abuse-resistant controlled-release opioid dosage form |
| 04/17/2014 | US20140107145 Compositions for drug administration |
| 04/17/2014 | US20140107144 Polymorph of rifaximin and process for the preparation thereof |
| 04/17/2014 | US20140107140 Compositions and methods for treatment of gulf war illness |
| 04/17/2014 | US20140107136 Compositions and methods for treatment and delaying the onset of diabetes |
| 04/17/2014 | US20140107135 Pyrimidinone inhibitors of lipoprotein-associated phospholipase a2 |
| 04/17/2014 | US20140107134 Compounds for inflammation and immune-related uses |
| 04/17/2014 | US20140107130 Oral Solution Formulations of Aripiprazole |
| 04/17/2014 | US20140107125 Hydrazonopyrazole derivatives and their use as therapeutics |
| 04/17/2014 | US20140107124 Novel prostamides for the treatment of glaucoma and related diseases |
| 04/17/2014 | US20140107123 Therapeutic Methods For Type I Diabetes |
| 04/17/2014 | US20140107121 Olopatadine compositions and uses thereof |
| 04/17/2014 | US20140107120 Dual-acting benzoimidazole antihypertensive agents |
| 04/17/2014 | US20140107119 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 04/17/2014 | US20140107118 Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders |
| 04/17/2014 | US20140107116 Benzothiazole derivatives for the treatment of diabetes |
| 04/17/2014 | US20140107114 Combination Therapy Comprising A CDK4/6 Inhibitor and a P13K Inhibitor for Use in the Treatment of Cancer |
| 04/17/2014 | US20140107113 Pharmaceutical composition comprising a trpa1 antagonist and a beta-2 agonist |
| 04/17/2014 | US20140107111 Use of sigma ligands in diabetes type-2 associated pain |
| 04/17/2014 | US20140107108 Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and process for preparing them |
| 04/17/2014 | US20140107104 Combination medicine for treatment of depression |
| 04/17/2014 | US20140107102 Ocular Allergy Treatments |
| 04/17/2014 | US20140107101 Macrocyclic Indole Derivatives Useful as Hepatitis C Virus Inhibitors |
| 04/17/2014 | US20140107097 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt |
| 04/17/2014 | US20140107096 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt |
| 04/17/2014 | US20140107095 Estrogen receptor modulators and uses thereof |
| 04/17/2014 | US20140107094 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt |
| 04/17/2014 | US20140107091 Process for the production of estetrol intermediates |
| 04/17/2014 | US20140107090 Treatment and prevention of mastitis |
| 04/17/2014 | US20140107088 Medical devices and methods comprising an anabolic agent for treatment of an injury |
| 04/17/2014 | US20140107087 Methods, Compounds and Pharmaceutical Compositions for Treating Anxiety and Mood Disorders |
| 04/17/2014 | US20140107086 System and Method for Diagnosis and Treatment |
| 04/17/2014 | US20140107085 Bifunctional AKR1C3 Inhibitors/Androgen Receptor Modulators and Methods of Use Thereof |
| 04/17/2014 | US20140107084 Ultra low dose doxepin and methods of using the same to treat sleep disorders |
| 04/17/2014 | US20140107083 Treatment of congestion using steroids and adrenergics |
| 04/17/2014 | US20140107082 Method and Compositions for Treating Psoriasis |
| 04/17/2014 | US20140107081 Salicylic acid topical formulation |
| 04/17/2014 | US20140107080 Brain function improving agent |
| 04/17/2014 | US20140107079 Beta-hydroxy-gamma-aminophosphonates for Treating Immune Disorders |
| 04/17/2014 | US20140107072 New Method For Making Krill Meal |
| 04/17/2014 | US20140107071 Methods of manufacturing topical compositions and apparatus for the same |
| 04/17/2014 | US20140107068 Marker for determination of sensitivity to anticancer agent |
| 04/17/2014 | US20140107067 Compositions comprising dietary fat complexers and methods for their use |
| 04/17/2014 | US20140107065 Biopolymer System for Tissue Sealing |
| 04/17/2014 | US20140107064 Glycosaminoglycan oral use and compositions |
| 04/17/2014 | US20140107063 Osteoarthritis diet formulations |
| 04/17/2014 | US20140107062 Compositions and methods for treating or preventing diseases of body passageways |
| 04/17/2014 | US20140107060 Fused Pentacyclic Polyethers |
| 04/17/2014 | US20140107058 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 04/17/2014 | US20140107057 Pesticidal mixtures including isoxazoline derivatives |
| 04/17/2014 | US20140107054 Method of treating clostridium difficile-associated diarrhea |
| 04/17/2014 | US20140107053 Apples with high polyphenolic content |
| 04/17/2014 | US20140107052 Edible composition |
| 04/17/2014 | US20140107051 Isoflavones for treating mucopolysaccharidoses |
| 04/17/2014 | US20140107050 Increasing bioavailability of n-coumaroyldopamine through co-administration with a catechol-o-mehtyltransferase (comt) inhibitor |
| 04/17/2014 | US20140107047 Cosmetic compositions for increasing bioavailability of active compounds |
| 04/17/2014 | US20140107045 Method for treatment of disease with pure porcine monosialoganglioside gm1 |
| 04/17/2014 | US20140107040 Substituted n-aryl pyridinones |
| 04/17/2014 | US20140107038 Method for administering omega-conopeptide |
| 04/17/2014 | US20140107032 Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events |
| 04/17/2014 | US20140107025 Ocular drug delivery system |
| 04/17/2014 | US20140107024 Treatment of Type 2 Diabetes With FTY720 |
| 04/17/2014 | US20140107017 Methods for Treating HCV |
| 04/17/2014 | US20140107016 Methods for Treating HCV |
| 04/17/2014 | US20140107012 Trehalulose-containing composition, its preparation and use |
| 04/17/2014 | US20140106450 Compositions and Methods for Inhibiting Expression of a Target Gene |
| 04/17/2014 | US20140106014 Integrated Neuromodulation System for Mood Enhancement of a Living Human Subject |
| 04/17/2014 | US20140106012 Compositions and methods useful for treating pediculosis |
| 04/17/2014 | US20140106006 Synergistic Combination For The Treatment of Type 2 Diabetes Mellitus |
| 04/17/2014 | US20140106005 Compositions And Methods Of Use Of Phorbol Esters In The Treatment Of Neoplasms |
| 04/17/2014 | US20140106003 Thioxanthone-Based Autophagy Inhibitor Therapies to Treat Cancer |
| 04/17/2014 | US20140106002 Homeopathic composition and method for the treatment of skin irritations and other skin diseases |
| 04/17/2014 | US20140105999 Oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders |
| 04/17/2014 | US20140105989 Treatment Methods with Low-Dose, Longer-Acting Formulations of Local Anesthetics and Other Agents |
| 04/17/2014 | US20140105987 Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
| 04/17/2014 | US20140105986 Topical compositions |
| 04/17/2014 | US20140105985 Topical use of levofloxacin for reducing lung inflammation |
| 04/17/2014 | US20140105984 Reduction of flake-like aggregation in nanoparticulate active agent compositions |